We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Novel Device Enables Rapid Identification of Brain Cancer Type

By LabMedica International staff writers
Posted on 20 Oct 2016
Print article
Image: Immuno-wall chips with the photo reactive polymer in the center of the 40 microchannels are made with a biotinylated anti-R132H-IDH1 antibody (HMab-2), an anti-wild-type IDH1 antibody (RcMab-1), and fluorescent antibodies. It shows sensitive and specific fluorescence from mutant IDH1 (Photo courtesy of Nagoya University).
Image: Immuno-wall chips with the photo reactive polymer in the center of the 40 microchannels are made with a biotinylated anti-R132H-IDH1 antibody (HMab-2), an anti-wild-type IDH1 antibody (RcMab-1), and fluorescent antibodies. It shows sensitive and specific fluorescence from mutant IDH1 (Photo courtesy of Nagoya University).
A device has been developed for quick, accurate identification of a mutation strongly associated with a cancer that affects the central nervous system, potentially enabling accurate removal of the entire tumor during an operation.

Gliomas are tumors occurring in the brain or spinal cord and are difficult to treat as they lack a clear edge, which complicates full surgical removal, which leads to high levels of recurrence and mortality. A particular mutation that is very common in gliomas has been identified, but is rare in other cancers and in normal tissue.

Scientists at the Nagoya University (Japan) collected fresh tumor samples, 5–10 mm in diameter intraoperatively from 10 patients whose tumors were resected in 2015. The location of each sample was recorded stereotactically in an intraoperative navigation system. Each tumor tissue was dissected into three pieces for the immuno-wall assay, immunohistochemistry, and DNA sequencing.

The scientists used various techniques including cell lines expressing mutated or wild type isocitrate dehydrogenase 1 (IDH1), protein lysates, Western blotting, direct sequencing for IDH1 mutation were carried out using an ABI 3100 Genetic Analyzer (Applied Biosystems, Forest City, CA, USA). Detection and calculation of the frequency of the mutant allele was performed using pyrosequencing technology (Pyrosequencing AB, Uppsala, Sweden). An immuno-wall assay was developed using immuno-wall chips with 40 microchannels (1 mm width, 40 μm height and 8.5 mm length each) in a cyclic-olefin-polymer substrate were constructed using photolithography.

The device features a chip with an attached highly specific antibody, which binds to the protein produced by the gene in which the mutation has occurred. When a sample containing the mutated protein is added to the device, the protein binds to the antibody, which is then specifically detected by a source of fluorescence. In contrast, if the sample is from normal tissue without this mutation, or is from a tumor other than a glioma, no fluorescence occurs. The small sample size required for the device reduces the invasiveness of sample harvesting. In fact the process takes only 15 minutes, enabling completion during an operation. The immuno-wall could markedly increase success of glioma treatment by rapidly providing data to inform the course of the operation and tissue to remove.

The authors commented that the immuno-wall determines whether a sample is positive for a specific mutation in the isocitrate dehydrogenase 1 gene, which is present in around 70%-80% of grade II and III gliomas. Our results for a range of cancerous cell lines and actual tumor samples both positive and negative for this mutation were very promising. The device was proven highly accurate, as confirmed by complete sequencing of the gene in question in each sample. The study was published on October 4, 2016, in the journal Science and Technology of Advanced Materials.

Related Links:
Nagoya University
Applied Biosystems
Pyrosequencing AB
Gold Member
Blood Gas Analyzer
GEM Premier 7000 with iQM3
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Urine Bone Markers Control
Lyphochek Urine Bone Markers Control
New
Food Allergens Assay Kit
Allerquant 14G A

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Molecular Diagnostics

view channel
Image: Schematic overview of maternal biomarker discovery using cell-free RNA during pregnancy (Photo courtesy of Circulation Research (2024). DOI: 10.1161/CIRCRESAHA.124.325024)

Maternal Blood Test Identifies Congenital Heart Diseases in Fetus

Each year, around 1,000 children are born with a single ventricle heart defect (SVHD), a condition where one of the heart's lower chambers is underdeveloped, too small, or missing a valve.... Read more

Hematology

view channel
Image: QScout CBC will give a complete blood count in 2 minutes from fingerstick or venous blood (Photo courtesy of Ad Astra Diagnostics)

Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results

Every hour is critical in protecting patients from infections, yet there are currently limited tools to assist in early diagnosis before patients reach a hospital. The complete blood count (CBC) is a common... Read more

Microbiology

view channel
Image: The InfectoSynovia test has the potential to revolutionize the diagnosis of periprosthetic joint infection (Photo courtesy of 123RF)

High-Accuracy Bedside Test to Diagnose Periprosthetic Joint Infection in Five Minutes

Periprosthetic joint infection (PJI) represents a significant global issue that is worsening as the number of joint replacements increases due to aging populations. In the United States alone, the anticipated... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.